Aloe emodin

Anthraquinones

NP0908

481-72-1

Aloe emodin

Aloe-emodin is an interferon-inducing agent with IC50 of about 1 μg/mL for JEV and of about 0.33 μg/mL for EV71. Aloe-emodin has anti-tumor activity, antibacterial activity, immunosuppressive effect, and purgative effect. It is now widely used as a raw material for medicines and cosmetics.

Aloe-emodin;Aloe emodin;481-72-1;Aloeemodin;Aloe-emodine;Rhabarberone;1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione;3-Hydroxymethylchrysazine;3-Hydroxymethylchrysazin;EMODINE;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;1,8-Dihydroxy-3-hydroxymethylanthraquinone;9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-;1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione;NSC 38628;CCRIS 3526;UNII-C8IYT9CR7C;C8IYT9CR7C;3-(Hydroxymethyl)chrysazin;EINECS 207-571-7;BRN 2059062;CHEBI:2607;DTXSID2030695;NSC-38628;CHEMBL40275;1,8-dihydroxy-3-hydroxymethyl-anthraquinone;DTXCID0010695;Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-;4-08-00-03578 (Beilstein Handbook Reference);NSC38628;1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone;MFCD00017373;ANTHRAQUINONE, 1,8-DIHYDROXY-3-HYDROXYMETHYL-;DIHYDROXY-3-HYDROXYMETHYLANTHRAQUINONE, 1,8-;1,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin);SMR000470920;AloeEmodine;Aloe-emodol;Rottlerin?;Aloe-Emodine,(S);ALOE-EMODIN [MI];cid_10207;MLS000697563;MLS006011799;SCHEMBL309756;Aloe-emodin, analytical standard;Aloe-emodin, >=95% (HPLC);HMS3655N16;BCP28272;EX-A6788;HY-N0189;Tox21_302400;AC-020;BBL027838;BDBM50085551;LMPK13040002;s2259;STL146380;AKOS005720864;CCG-208456;CS-3709;9, 1,8-dihydroxy-3-(hydroxymethyl)-;SMP2_000291;NCGC00163510-01;NCGC00163510-02;NCGC00163510-03;NCGC00255349-01;AS-11638;CAS-481-72-1;NCI60_003685;NS00018020;SW219916-1;Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-;SR-01000765772;Q-100526;Q3533249;SR-01000765772-3;BRD-K04851519-001-06-8;1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #;1,8-Dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9CI;9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene;Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard;1,8-DIHYDROXY-3-(HYDROXYMETHYL)-9,10-DIHYDROANTHRACENE-9,10-DIONE;InChI=1/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H;

1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione

270.24

C15H10O5

O=C1C2=C(C=CC=C2O)C(C3=CC(CO)=CC(O)=C13)=O

InChI=1S/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H2

YDQWDHRMZQUTBA-UHFFFAOYSA-N

568.8±50.0 °C at 760 mmHg

223-224°C

>98%

1.6±0.1 g/cm3

Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)

Solid

antineuroectodermal tumor

Store at -20°C under inert atmosphere

Powder

5 g